Editorial Board

Dr. Vahit Ozmen is a Professor of Surgery in the Department of Surgery, at the Istanbul Faculty of Medicine Istanbul University, and Chairman of the Breast Center, Istanbul Florence Nightingale Hospital. He is also a Board Member of the Turkish Cancer Institute, and Chairman of the Standing Committee of Senologic International Society (SIS).

After graduating from Istanbul University Istanbul Faculty of Medicine started to work as a resident in the Department of Surgery and continued his academic career at the same faculty. He was invited as a post-doctoral fellow by Tulane University School of Medicine in 1989 and returned to his faculty in 1991. He also worked as a visiting professor and gave lectures in the University of Pittsburgh Medical Center, MD Anderson Cancer Center, Mayo Clinics, and Tokai University, Japan for short periods. He has an honorary diploma and medal from the Bulgarian Surgical Society to promote breast health care in Bulgaria. He is the founder and past-president of the Turkish Federation of Breast Disease Societies, Istanbul Breast Society, and founder and Honorary President of The Breast Health Society.

Dr. Ozmen is Editor-in-Chief in the European Journal of Breast Health and Surgical Science, and Academic Editor of the PLOS ONE, International Journal of Surgical Oncology and Cureus Journals. He has more than 200 peer-reviewed publications, over 200 presentations in scientific meetings, more than 50 chapters in textbooks. He received research grants from the BHGI, GeneCore, Roche Oncology, and Novartis Oncology. He is also the editor of the Textbook of Breast Diseases and Breast Cancer in Türkiye. He also received many prizes for his researches and studies.

Dr. Ozmen was principal investigators of many granted prospective clinical trials such as Bahcesehir Organized Population-Based Mammography Screening Project (2008-2018), and Breast Cancer Registry Program in Türkiye.

Atilla Soran,MD, MPH, FNCBC, FACS is a Professor of Clinical Surgery at the University of Pittsburgh. Dr. Soran is the Director of the Breast Disease Clinical Research Program, Comprehensive Lymphedema Program and International Breast Fellowship Program, and served as the Associate Medical Director, UPMC International Oncology Development previously. Dr. Soran has a long history of serving as a chair or a being a member on many scientific research committees such as The American Society of Breast Disease, The American Society of Clinical Oncology Breast Cancer Symposium Program, and NCBC International Program. Dr. Soran was appointed as a Board Member the NCBC in 2015 and International Committee Chair in 2016 and he also serves as a member of other prestigious associations such as American College of Surgeons. Dr. Soran has more than 160 publications, over 200 presentations in scientific meetings, and has more than 50 review articles and chapters in textbooks. Dr. Soran has received 39 national and international awards and honors. Dr. Soran is on the editorial board and reviewer in several medical journals. Dr. Soran was invited to several scientific meetings all over the world as a lecturer and moderator. Dr. Soran has conducted several clinical studies and received grants for his research. He has been recognized as an investigator by the National Cancer Institute in the USA and he has been serving a DOD- Congressionally Directed Medical Research Programs for Breast Cancer as a panel member for more than 10 years; he also initiated several studies internationally and is being chaired them. Dr. Soran initiated a new program first time in the World entitled “Lymphedema Screening, Early Detection and Intervention/Prevention Program. He is world well-known surgeon for the study of surgery for metastatic breast cancer. More than 80 international physicians have been trained by him in his program; Dr. Soran provides scholarship to international scientists while they are working as a research scientist in the USA.

In addition doing workshops internationally, in 2020 he founded the Breast Health Working Group Internationally and since then he is the chair of the group and he leads the breast health tumor board international every week. He has created very competitive scholarship in the Turkish National Surgical Society. He is currently Charing Senologic International Society Education and clinical trial committee and NCBC abstract committee. He is the editor in the European Journal Breast Health.

Alexander Mundinger was born in Freiburg, Germany. After his school education in Freiburg, he studied Medicine and received accreditation in internal medicine and radiology. His habilitation at the University of Freiburg focussed on MRI and rheumatic disorders. Professor Alexander Mundinger is head of the Department of Radiology at the academic Niels-Stensen Clinics; Marienhospital Osnabrück since October 1995, where he earned a reputation in senology, general radiology, interventional radiology and cardiac MRI. In addition, Professor Mundinger was director of the Radiological Center of Niels-Stensen-Clinics and head of the Section of Breast Imaging and Minimal Invasive Procedures in the certified Breast Centre Osnabrück located in Franziskus Hospital in Georgsmarienhuette. He held the position of President from 2005 to until the end of 2011 at the International Breast Ultrasound School (IBUS), and continues on the IBUS Executive Council in the capacity of Chairman of the Executive Alumni. After having served on the board of Senologic International Society (SIS) as Vice President for Europe Professor Mundinger served as President of SIS for the tenure of 2015-16 and continues acting as auditor of SIS. Professor Mundinger serves as German national consensus expert in all imaging. Since 2020 he has dedicated himself exclusively to breast imaging modalities and interventions.

Dr. Banu Arun is Professor in Department of Breast Medical Oncology, Co-Medical Director of the Clinical Cancer Genetics Program and Section Chief Breast Genetics, Prevention and Screening at the University of Texas MD Anderson Cancer Center. Her research focuses on identifying risk biomarkers for breast cancer and prevention, and characterizing risk factors in a cohort of high-risk women with hereditary gene mutations (BRCA and others) as well as assessing breast cancer biology in these patients. She has served as the Principal Investigator on several clinical trials evaluating agents such as letrozole, imatinib, gemcitabine, R115777 and PARP inhibitors for metastatic breast cancer (including BRCA positive,) and celecoxib, atorvastatin and dasatinib in short-term breast cancer prevention trials. Her research also include outreach and education. As well as cascade genetic testing of family members.

Given her national and international expertise she has served in several committees, including The American Society of Clinical Oncology (ASCO) Prevention committee and currently serves as the Co-Chair for the Southwest Oncology Group (SWOG) Prevention and Epidemiology Committee and member of the NCCN Breast Cancer Risk Reduction Guideline Committee, member of the ASCO BOLD task force, member of ASCO Prevention Education committee, and member of the National Cancer Institute (NCI) Cancer Prevention Steering Committee. She served as grant reviewer for Susan Komen and NCI P01 and reviewed for journals including JCO, Cancer, BMJ, Cancer Prevention and Epidemiology, amongst others. She has more than 200 peer reviewed publications and received research grants from the NCI, Susan Komen Foundation and CPRIT.

She was also featured in Forbes (December 2017) as one of the top 30 Breast Medical Oncologists in the United States. She has also received FASCO award recognition in 2020 from the American Society of Clinical Oncology.

Baṣak Dogan, M.D., FSBI, is Associate Professor of Radiology and Eugene P. Frenkel Endowed Scholar in Clinical Medicine at UT Southwestern Medical Center, where she serves as a member of its Breast Imaging Division and the Director of Breast Imaging Research.

Dr. Dogan earned her medical degree at Hacettepe University in Ankara, Türkiye, and completed her residency training in diagnostic radiology at Ankara University Medical School. She received advanced training in breast imaging through a fellowship program at the University of Texas MD Anderson Cancer Center in Houston.

Prior to joining the UT Southwestern faculty in 2016, she was an associate professor at MD Anderson, where she also served as Medical Director of the MD Anderson Ben and Julie Rogers Main Campus Breast Diagnostic Clinic.

Dr. Dogan’s research interests include advanced breast magnetic resonance imaging applications, optoacoustic imaging, and microbubble contrast-enhanced ultrasound of sentinel lymph nodes. She has authored or co-authored more than 67 peer-reviewed publications, abstracts, and book chapters and is frequently an invited speaker at many national and international conferences.

In addition to serving UT Southwestern as a member of the Cancer Committee, she is also a member of the Radiology Department’s Research Day Abstract Review Committee. Nationally, she serves on the National Cancer Comprehensive Network and the American Society of Clinical Oncology's TCGA/TCIA Breast Research Group.

She is an active member of several professional societies, including the Radiological Society of North America, the American Roentgen Ray Society, and the College of American Radiology, and she is a Fellow of the Society of Breast Imaging.

Dr. Carole Mathelin is a Professor of Surgery at the Faculty of Medicine of the University of Strasbourg and Head of the Department of Surgery at the Strasbourg Europe Cancer Institute (ICANS), France. She has been elected President of the International Society of Senology (SIS) for the 2026–2028 term and currently serves as President of the Senology Commission of the French National College of Gynecologists and Obstetricians (CNGOF). In 2025, she was appointed President of the National Academy of Surgery of France.

She completed her medical training in Gynecology and Obstetrics at the University of Strasbourg, where she also received her Doctorate in Medicine and the Qualification to Supervise Research (HDR). She obtained an Advanced Studies Diploma (DEA) in Surgical Sciences from the University of Paris XI and a Complementary Specialized Studies Diploma (DESC) in Oncology.

Dr. Mathelin previously held posts as an intern, senior physician, and hospital assistant in gynecology and obstetrics before becoming a full hospital practitioner and later a university professor. She is also a founding member of the Sino-French School of Senology in Chongqing, China, and was elected as a Corresponding Member of the Brazilian National Academy of Medicine in 2025.

She has authored over 200 peer-reviewed publications and an additional 200 non-peer-reviewed articles, contributed to 45 book chapters, and co-authored the book Breast Cancer (2007). Her innovative work led to two patents in the field of breast health technologies.

Dr. Mathelin’s achievements have been recognized with several prestigious honors and awards, including the title of Chevalier de la Légion d’Honneur. She was awarded the Senometry and Lymphometry Innovation Prizes at the CES in Las Vegas (2018, 2019), the Ruban Rose Avenir Prize for Environment and Breast Cancer (2021), the Bas-Rhin Cancer League Prize (2024), and a grant from Fondation de France.

Erkin Arıbal is a Professor in the Radiology Department of Acibadem M.A.A. University Hospital. He is the head of the Breast Imaging Unit of Acibadem Altunizade Hospital, member of the Multidisciplinary Breast Team, and member of the Oncology Board. He is one of the founders of the Marmara Breast Center in 2001. He was the president of the Breast Imaging Group of the Turkish Radiological Society from 2011 to 2013. He is on the Breast Cancer Advisory Board of the Ministry of Health in Türkiye and serves as an advisor for the National Breast Screening Project. Prof. Arıbal has authored or co-authored more than 100 refereed journal or full conference proceedings papers. He is also a founder and member of SenaTurk Academy, an initiative aiming to develop teaching materials and programs for horizontally and vertically integrated education in breast health. He is an executive board member of the Breast Health Society (Memeder), a non-profit organization consisting of breast cancer survivors and scientists specializing in breast cancer. Memeder implemented Türkiye’s first population-based breast screening project in Bahcesehir, which later became a prototype for the national screening program. He is currently the President of the International Breast Imaging School (IBUS), headquartered in Zurich.

Dr. Aktepe is Professor of Pathology, Memorial Hospital, Istanbul. Her main scientific interests are on breast pathology, uropathology, molecular pathology and digital pathology. In recent years, Dr. Aktepe has been working especially on tumor-infiltrating lymphocytes in breast cancers.

Dr.Aktepe graduated from Anadolu University Medical School. She completed her residency in Pathology Ankara Oncology Hospital. She conducted many projects supported by TUBİTAK. She worked in Pathology Department in Osaka University for 3 months to develop her skills in molecular pathology. She was at the Department Pathology, Ghent University in 2010 as part of Erasmus exchange program on breast pathology.

Dr. Karadeniz Çakmak has been a Professor of Surgery at Zonguldak Bülent Ecevit University, School of Medicine since 2010. She earned her M.D. from Istanbul University, Cerrahpaşa Medical School in 1999 and worked at the Breast Surgical Service in 2012 and the Plastic and Reconstructive Surgery Department in 2018 as an invited international scholar at Memorial Sloan Kettering Cancer Center, New York, USA.

Since 2014, she has been serving as the Chief of the Department of General Surgery and the Head of the Breast and Endocrine Surgery Unit. Dr. Karadeniz Çakmak has also been the Head of the Division of Surgical Sciences since 2020. She is the founding president of the Western Black Sea Region Breast Diseases Association and has been serving as its president since 2017. Dr. Karadeniz Çakmak obtained the European Board of Surgery Qualification in Breast Surgery and was accepted as a Fellow of the American College of Surgeons in 2017. In 2018, she was awarded the American College of Surgeons (ACS) / American Society of Breast Surgeons (ASBrS) International Scholarship.

She has received research grants funded by Zonguldak Bülent Ecevit University and The Scientific and Technological Research Council of Türkiye (TÜBİTAK). Dr. Karadeniz Çakmak has been a member of the Research Ethics Committee since 2010. Her research interests include breast cancer, oncoplastic breast surgery, intraoperative breast ultrasound, and sentinel lymph node mapping. Her laboratory and clinical research focus on surgical treatment modalities for locally advanced breast cancer and neoadjuvant therapies. She has participated in several national and international multicenter clinical trials and has authored over 50 scientific publications as well as delivered numerous presentations, lectures, and workshops both nationally and internationally.

Dr. Soybir is Professor of Surgery at the İstanbul Memorial Hospital since 2014. He was trained in general surgery in İstanbul Taksim Research Hospital, and studied as a research fellow in the same hospital. He settled Taksim Hospital Experimental Research Laboratory. He was associate Professor and cheif assistant in Haseki Research Hospital for ten years. He was the founder of General Surgery and also Breast Surgery departments in Namık Kemal University in Tekirdağ, and worked as Professor of Surgery for 4 years. He also established Breast Cancer Research Unit in the university and Assocciation of Tekirdağ Breast Disease.

Since 20014, he is working as professor of breast surgery in Istanbul Memorial Hospital. Prof. Soybir also worked as fellow or visiting surgeon for different periods in different breast disease units of the World such as; Nothingham City Hospital, England; MD Anderson Cancer Center, Houston, USA; Kameda Endoscopic Breast Surgeyi Unit, Japan; Pittsburgh Magee Women Hospital Oncoplasitc Breast Surgery Unit, USA; and Dusseldorf, European Academia of Senology, Oncoplastic Breast Surgery, Germany.

Dr. Soybir is the fellowship of American College of Surgeons since 2001. He was one of the founders of the Turkish Chapter of American College of Surgeons and also the general secretary of that society for two years.

Dr. Soybir has been certified by Turkish Surgical Board in 2003. He won a lot of Scientific Research Prizes in different national and international congress.

He has been the member of the Turkish Federation of Breast Disease Associations and also Society of Istanbul Surgery.

He was the general secretary of Turkish Journal of Surgery for 6 years. He has been in the editorial board of several national and international journals in different periods. He is the Assistant Editor of European Journal of Breast Health since 2012.

He has a lot of medical books and book chapters. He is colloborated in several scientific publications, oral and poster presentations. He has been advisor for a lot of assistant thesis. He has been assigned for a lot of times as panelist, lecturer, moderator or member of organizing congress committee.

He is the members of a several national and international scientific medical societies Dr Soybir’s main interests are breast cancer, breast surgery, oncoplastic breast surgery and endoscopic breast surgery.

Dr. Ismail Jatoi is Professor and Chief of the Division of Surgical Oncology and Endocrine Surgery at the University of Texas Health Sciences Center in San Antonio, Texas. He is the holder of the Dale H. Dorn Endowed Chair in Surgery. Dr. Jatoi obtained his undergraduate bachelor’s degree from Washington University in St. Louis and his MD and PhD degrees from St. Louis University. He is a diplomate of the American Board of Surgery and a fellow of the American College of Surgeons. He completed fellowship training in surgical oncology at the Royal Marsden Hospital in London, England. Dr. Jatoi was formerly a Professor of Surgery at the Uniformed Services University in Bethesda, Maryland, and continues to hold an Adjunct Professor appointment at that institution. Dr. Jatoi has had a longstanding interest in breast cancer local therapy and adjuvant systemic therapy, the management of women at increased risk for breast cancer, and breast cancer screening. He also has an interest in the design and analysis of cancer clinical trials. Dr. Jatoi has previously served on the Breast Cancer Executive Committee of the Southwest Oncology Group (SWOG). He is the co‐Principal Investigator of the NRG Oncology effort at the University of Texas Health Science Center in San Antonio and serves on the national NRG Oncology Breast Cancer Committee and Working Group. Dr. Jatoi serves on the Executive, Planning, and Abstract Review Committees of the San Antonio Breast Cancer Symposium (SABCS), and was Interim Co‐Director of the SABCS in 2014.

Dr. Nuran Beşe is a Professor in radiation oncology at the Clinical Senology Department of Acibadem Research Institute of Senology.

Her training as a M.D and radiation oncologist was completed in Istanbul University, Cerrahpasa Medical School. During her education in radiation oncology, she was awarded British Council Scholarship and worked as a visiting clinician in Royal Marsden Hospital/Sutton. She worked as a consultant for the development of radiation oncology in member states in International Atomic Energy Agency/ Vienna in 2006. She became Associate Professor in 2000 and Professor in 2006.

She has participated in the preparation of many national and international breast cancer guidelines and she has more than 110 national and international publications. Currently she is the head of Turkish Radiation Oncology Society, Breast Cancer Working Party.

Her memberships are: American Society for Therapeutic Radiology and Oncology (ASTRO),

European Society for Therapeutic Radiology and Oncology (ESTRO)

Association of Radiotherapy and Oncology of the Mediterranean area (AROME) –Board member,

International Society of Intraoperative Radiotherapy (ISIORT),

Multidiciplinary Oncology Society –Türkiye (MDOD)–Vice president

Europa Donna, Türkiye –Board member

Women in Nuclear (WIN) , Türkiye

Dr. Osman Zekioğlu is Professor of Pathology at Ege University, Faculty of Medicine. He has graduated from Dokuz Eylül University, Medical School in 1992. He completed his residency in Pathology in Ege University Faculty of Medicine in 1998. He studied gynecologic pathology in Pathology at Ege University between 2000-2004. He served as a member of the board of the Ege Pathology Association between 2004-2008. His scientific interests mainly relate to breast, and gynecologic pathology.

Tibor Tot is associate professor of pathology at Uppsala University and consultant pathologist/former head of Pathology & Cytology Dalarna at the County Hospital in Falun, Sweden. He is past chair of the European Society of Pathology Breast Working Group and long-time faculty member in the breast pathology arm of the European School of Pathology. He is invited faculty member in European School of Radiology, one of the scientific directors in the European School of Oncology Certificate of Competence in Breast Cancer program, and external expert in the European Commission’s breast center certification working group. His main fields of interest are breast pathology, colorectal pathology and immunohistochemistry. He is repeatedly invited lecturer at international and national congresses, symposia, and teaching courses all over the world, author of co-author of textbooks, book chapters, and more than 100 peer-reviewed journal articles.

Dr. Didier Verhoeven is medical oncologist working in AZ KLINA, Brasschaat, Belgium, He is head of the department Medical Oncology and Hematology.

He was a trainee of Prof. AT. Van Oosterom and is currently Clinical Director of the “Breast Clinic Voorkempen” which treated nearly 300 new cases of breast cancer a year. (Accreditation by EUSOMA since 2015)

Dr. D. Verhoeven defended his PhD. thesis about breast cancer: “Tumor cell proliferation and stromal changes in breast cancer” at the University of Antwerp in 1992. In addition he obtained a Master degree in medical and pharmaceutical research at the University of Brussels.

He wrote many papers about oncology especially about breast cancer in international and national peer reviewed journals. He is member of a lot of cancer societies. Although he is a real clinician, part of his work goes to data management and quality improvement programs. 1/11/2014 he was appointed as guest professor medical oncology (topic: Quality in Oncology) at the University of Antwerp. February 2015 he was the driving force and chair of the 5the International Congress of Breast Disease Centers in Antwerp. In 2018 Oxford University Press accepted his book: “Breast Cancer : Global Quality Care ” for publication (14/11/2019 ) ( co-editors : C.Kaufman, US, R.Mansel, UK and S.Siesling, The Netherlands ; with extensive book review in ASCO-Post, 2020 ). November 2019 he was the chair and local responsible for the organisation of the 3the International Oncology Leadership Conference in Antwerp.

Dr. Erol Kozanoğlu is a dedicated Plastic Reconstructive and Aesthetic Surgeon with a specialized focus on breast surgery and maxillofacial surgery. He earned his Medical Degree from İstanbul University İstanbul Faculty of Medicine in 2010, followed by the completion of his residency in Plastic Reconstructive and Aesthetic at from İstanbul University İstanbul Faculty of Medicine, Department of Plastic Reconstructive and Aesthetic Surgery. To further refine his expertise, Dr. Kozanoğlu completed advanced practice at the same institution.

Currently serving as an Associate Professor at İstanbul University İstanbul Faculty of Medicine, Department of Plastic Reconstructive and Aesthetic Surgery, Dr. Kozanoğlu has cultivated extensive clinical experience in the reconstructive and aesthetic surgery of the breast. His clinical practice prioritizes oncoplastic techniques and multidisciplinary breast cancer care, ensuring patients receive evidence-based and comprehensive surgical treatment.

Academically, Dr. Kozanoğlu is an active contributor to the scientific community. He has authored multiple peer-reviewed articles published in national and international journals, with a particular research interest in breast reconstruction, skin oncology and maxillofacial surgery. He regularly participates in surgical congresses and is an active member of professional organizations such as the Turkish Society of Plastic Reconstructive and Aesthetic Surgery, Turkish Society of Reconstructive Microsurgery, Maxillofacial Surgeons Society of Türkiye, Emergency Hand Care and Microsurgery Society and Turkish Society of Cleft Lip and Palate.

As an incoming academician, Dr. Kozanoğlu is committed to advancing the field of breast surgery by upholding rigorous scientific standards. He aims to facilitate the dissemination of high-quality research that bridges the gap between clinical practice and surgical innovation, fostering a collaborative environment for researchers and clinicians alike.

Neslihan Cabıoğlu, M.D., PhD FACS FEBS, is Professor of Surgery at the İstanbul University, İstanbul Faculty of Medicine, Department of General Surgery, İstanbul, Türkiye, where she works as a faculty at the Breast Unit.

Dr. Cabıoglu earned her medical degree at İstanbul University, İstanbul Faculty of Medicine in İstanbul, Türkiye, and completed her residency training in surgery at İstanbul University İstanbul Faculty of Medicine. She also gained PhD degree at the Department of Immunology of the Aziz Sancar Research Institute, İstanbul University. As a surgical fellow, she completed a 3-year postdoctoral research fellowship program in breast oncology and cancer biology at the University of Texas MD Anderson Cancer Center in Houston, at the Departments of Surgical Oncology, Cancer Biology and Breast Pathology. During her fellowship, she conducted important clinical, translational, and basic science research in breast cancer, leading to several prestigious publications.

Prior to joining faculty in İstanbul University in 2013, she was an associate professor at the Acibadem University, where she also served as Co-Director of the 4th year Medical Education Program at the Department of General Surgery. In 2014, she also became a Fellow of the European Board of Surgery in Breast Surgery.

Dr. Cabıoğlu’s research interests currently include sentinel lymph node biopsy in clinically node positive patients, targeted axillary dissection, lymphedema and quality of life, nipple discharge, ductoscopy, biological role of chemokine receptor expression in breast cancer, immune check point expressions in breast cancer, early detection and breast cancer screening in Türkiye, and local and complementary therapies in idiopathic granulomatous mastitis. She worked as an active member at the “Breast Health Society” (MEMEDER) since 2017 participating and leading important scientific research and breast cancer awareness activities. She has authored or co-authored more than 100 peer-reviewed high-impact publications including book chapters. She recently acted as a “Principal Investigator” of the Neo-SentiTürk Trial and “Coinvestigator” in several important prospective national and international studies including AXSANA-study about deescaalation of axillary surgery in clinically positive breast cancer. She succesfully completed and published some important reports in this area as a member of the research groups “EUBREAST” in Europe and “Turkish Breast Diseases and the Turkish Federation of Breast Diseases Societies (TFBDS)” in Türkiye. She is also the Coordinator of Turkish study sites in the MELODY-trial (MEthods for LOcalization of Different types of breast lesions) which is a EUBREAST study including 21 countries from all over the world and 23 study sites in Türkiye. She frequently serves as an invited speaker at major breast cancer–focused scientific meetings.

Furthermore, she has been an active member of several professional societies, including the American College of Surgeons, American Society of Breast Surgeons, Turkish National Surgical Society, and Turkish Breast Diseases and the Turkish Federation of Breast Diseases Societies.

Prof. Dr. Meena S. Moran is an internationally recognized leader in breast radiation oncology and Professor of Therapeutic Radiology at Yale School of Medicine. She has held major leadership roles, including Chief of the Yale Radiation Breast Program—where she served as division chief for over 10 years—and Medical Director across multiple institutions, including several of Yale’s radiation clinics over the span of her career, contributing to the integration of radiation oncology into comprehensive breast cancer care. She has played a central role in developing national guidelines and accreditation standards through organizations such as NCCN, ASTRO, ASCO, and the American College of Surgeons, and currently serves as Chair of the NCCN Breast Local-Regional Working Group and Vice Chair of the NCCN Breast Panel.

Dr. Moran’s research, with an H-index of 44, has significantly influenced modern breast cancer management, particularly in breast-conserving therapy, surgical margins, hypofractionation, and risk stratification. She is also a dedicated educator and mentor, an active contributor to board certification and training programs, and has served as associate editor and reviewer for leading oncology journals. With extensive international collaborations and educational efforts, she continues to shape global standards and improve breast cancer care worldwide.

Birol Topçu is a faculty member in the Department of Biostatistics at Namık Kemal University Faculty of Medicine in Tekirdağ. His main areas of interest are biostatistics, multivariate statistical models, mathematical statistics, and applied statistics.

He is the author and co-author of over 100 peer-reviewed journal articles, including books and books chapters. He has given numerous oral and poster presentations and supervised theses. He has served on scientific committees, including as a congress organizing member, scientific reviewer, and congress secretary. He has also served as an editor and associate editor for scientific journals and contributed to many scientific publications and presentations.

Prof. Dr. Efe Sezgin got his undergraduate degree at Middle East Technical University, and his PhD degree from Stony Brook University (New York, USA). He did his postdoctoral studies at National İnstitutes of Health (Maryland, USA). He was a Research Associate at Johns Hopkins Bloomberg School of Public Health till 2015.

He joined İzmir İnstitute of Technology as a faculty member in 2015.

His research areas cover Biostatistics, Epidemiology, Genetics and Genomics.